Tablet topic
Compounded Tirzepatide tablets
Questions to take to a clinician when an advertisement mentions tirzepatide in tablet form.

Compounded medicines are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before marketing. Package images are illustrations. Read the FDA’s guidance.
Check which form was studied
Approval information for an injection applies to that injectable product. A reference to tirzepatide in an advertisement does not establish how a tablet performs. Ask for evidence specific to the proposed tablet and its intended use.
Identify the preparation
Ask for the full product name, the dispensing pharmacy and the prescribing information. If it is compounded, the finished tablet has not been FDA-approved.
Bring your reason for asking
Perhaps you prefer a tablet, worry about needles or need a plan that fits a busy workday. Tell the clinician which concern matters most so you can discuss the full range of suitable options.
Explore other tablets

Tablet
Compounded Semaglutide tablets
Look up the exact tablet and discuss how the product, your other medicines and your schedule fit together.

Oral liquid
Compounded oral semaglutide
A dropper describes the container. Ask what the liquid contains, who prepared it and what evidence supports that formulation.